Award Raises USP's Profile in Shanghai FTZ
USP-China received the Outstanding Enterprise Award during an invitation-only roundtable discussion between FTZ-based organizations and the Chinese government.
USP's CEO Dr. Ron Piervincenzi relays his experiences and lessons learned from the 68th World Health Assembly held in Geneva, Switzerland, which he recently attended as a private advisor to the U.S. delegation led by Secretary of Health and Human Services, Sylvia Burwell.
USP staff had the opportunity to hear an animated and truly captivating presentation by Dr. Ian Crozier, an infectious disease physician who was infected with Ebola while treating patients during the Ebola outbreak in West Africa last year.
This World TB Day, Promoting the Quality of Medicines (PQM) program celebrates its achievement and commitment to taking an active role in reaching the millions of people with TB who are “missed” by health systems each year and do not get the care they need.
Poor quality medicines are the source of an alarming, but often overlooked global health crisis. A report from the International Policy Network estimates that 700,000 people die every year from fake anti-malarial and tuberculosis drugs alone.
Access to quality care and medicines is an integral part of public health. For USP, an organization that creates and promotes public standards for medicines and foods, quality and access are two sides of the same coin and in fact the absence of either one actually threatens effectiveness of medical care around the world.
USP Visiting Scientist Santiago Gallardo Dávila talks with USP about his work as a pharmaceutical chemist at the Mexican Pharmacopeia, and the intersection between chemistry and global health.
To help illustrate the true threat of counterfeit and substandard medicines, and demonstrate why USP and so many other organizations are working to improve drug quality, we offer this first-hand story about two near-fatal encounters with bad drugs.
Tuberculosis (TB) is one of the world’s most prevalent diseases – it kills three people every minute. Although progress has been made in expanding access to treatment, the rate of multi-drug resistant TB cases has nearly doubled between 2011 and 2012. One factor driving drug resistance is poor quality drugs. Several global health organizations have partnered together to find a solution to ensure that safe and effective medicines are used in their treatment programs.